CCl4 treatment triggered a mixed M1/M2 macrophage phenotype in fibrosis. Lower expression of PTEN in murine M2 macrophages in vivo and vitro. PTEN modulates M2 macrophages activation via PI3K/Akt/STAT6 signaling. Provide a new cellular target modulate macrophage mediated hepatic fibrosis.